×
About 95 results

ALLMedicine™ Apparent Mineralocorticoid Excess Center

Research & Reviews  38 results

Monogenic forms of low-renin hypertension: clinical and molecular insights.
https://doi.org/10.1007/s00467-021-05246-x 10.1038/s41569-020-00466-4 10.1007/s40620-019-00684-1 10.1007/s00431-011-1440-7 10.1007/s00467-007-0537-8 10.1038/s41588-018-0053-8 10.1007/s11154-018-9481-0 10.7554/eLife.06315 10.1136/bcr-2018-229031 10.1046/j.1440-1681.2001.03574.x 10.1038/355262a0 10.1016/S0021-9258(18)34909-3 10.1067/mpd.2001.112648 10.1038/sj.jhh.1001636 10.1161/01.HYP.31.1.445 10.1590/S0004-27302004000500014 10.1161/HYPERTENSIONAHA.111.180513 10.1161/01.HYP.38.3.688 10.1097/01.crd.0000096417.42861.ce 10.1530/EJE-17-0563 10.1210/jcem.86.10.7920 10.1210/jcem.83.7.4946 10.1111/j.1445-5994.1997.tb00999.x 10.1210/jcem.84.12.6256 10.1016/j.ecl.2011.01.012 10.1016/j.bbadis.2017.12.034 10.1126/science.1198785 10.1038/ng.2695 10.1530/EJE-19-0688 10.1161/HYPERTENSIONAHA.119.14349 10.1038/s12276-019-0337-9 10.1210/en.2016-1170 10.1038/ng0895-394 10.1073/pnas.1716621115 10.1007/978-1-4419-8002-1_10 10.1016/j.jsbmb.2016.03.010 10.1007/s12020-020-02460-9 10.1681/ASN.2006060570 10.1210/jc.2013-3254 10.1590/S0004-27302004000500015 10.1007/s004670000377 10.1007/s12098-020-03516-4 10.1159/000320117 10.1007/BF03343803 10.1016/j.etap.2017.02.021 10.1038/s41371-017-0002-5 10.1055/s-0032-1321851 10.1515/jpem-2018-0298 10.1016/j.jsbmb.2015.02.007 10.1210/jc.2003-031021 10.1210/jc.2003-030988 10.1073/pnas.1621082114 10.4274/jcrpe.0032 10.1530/EJE-19-0811 10.1210/jcem.87.4.8379 10.1126/science.289.5476.119 10.1530/JOE-17-0089 10.1073/pnas.0511184103 10.3390/ijms19030812 10.1007/s00431-011-1581-8 10.1152/ajprenal.00609.2019 10.1681/ASN.2016111163 10.1080/10641963.2017.1334799 10.1093/ajh/hpaa037 10.1007/s00467-003-1311-1 10.1097/00000441-200112000-00002 10.1007/s00467-014-2956-7 10.3390/genes10120986 10.1126/science.1062844 10.1038/nature10814 10.1515/jpem-2016-0309 10.1002/mgg3.705 10.1097/HJH.0000000000001039 10.1093/ajh/hpu083 10.1161/HYPERTENSIONAHA.110.168740 10.1111/jch.12598 10.1136/jmedgenet-2019-106145 10.1210/jc.2015-4061 10.1016/j.ancard.2015.04.017 10.1210/jc.2004-1149 10.1055/s-0031-1295460 10.1161/HYPERTENSIONAHA.110.155135
Pediatric Nephrology (Berlin, Germany); Khandelwal P, Deinum J

Aug 21st, 2021 - Monogenic disorders of hypertension are a distinct group of diseases causing dysregulation of the renin-angiotensin-aldosterone system and are characterized by low plasma renin activity. These can chiefly be classified as causing (i) excessive ald...

A life-threatening case of pseudo-aldosteronism secondary to excessive liquorice ingest...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349066
BMC Endocrine Disorders; McHugh J, Nagabathula R et. al.

Aug 8th, 2021 - Liquorice is found in many food products, soft drinks, and herbal medicines. Liquorice ingestion is an uncommon cause of apparent mineralocorticoid excess or pseudo-aldosteronism. The mechanism involves the inhibition of 11-beta-hydroxysteroid deh...

ERRATUM FOR: "Classic and Nonclassic Apparent Mineralocorticoid Excess Syndrome".
https://doi.org/10.1210/clinem/dgaa272
The Journal of Clinical Endocrinology and Metabolism;

Jan 14th, 2021 - ERRATUM FOR: "Classic and Nonclassic Apparent Mineralocorticoid Excess Syndrome".|2021||

Species-specific differences in the inhibition of 11β-hydroxysteroid dehydrogenase 2 by...
https://doi.org/10.1016/j.taap.2020.115387
Toxicology and Applied Pharmacology; Inderbinen SG, Zogg M et. al.

Jan 3rd, 2021 - 11β-hydroxysteroid dehydrogenase 2 (11β-HSD2) converts active 11β-hydroxyglucocorticoids to their inactive 11-keto forms, thereby preventing inappropriate mineralocorticoid receptor activation by glucocorticoids. Disruption of 11β-HSD2 activity by...

Apparent Mineralocorticoid Excess: Research as an Art Form.
https://doi.org/10.1007/s12020-020-02488-x
Endocrine Funder JW

Sep 30th, 2020 - Apparent Mineralocorticoid Excess: Research as an Art Form.|2020|Funder JW,|

see more →